CORE--CELL AND MOLECULAR BIOLOGY FACILITY

在预期的革命性影响， 分子生物学对糖尿病研究的影响， 糖尿病研究和培训中心（MDRTC）提出了一个分子 生物学核心（MBC）向其研究人员介绍这些技术 作为其1986年竞争更新申请的一部分。 因为 相关的研究基地刚刚建立，一个联合核心， 生殖与发育生物学中心。 研究基础薄弱，行政部门对联合国的关切 监督导致不赞成的核心，具有强烈的警示作用 用于随后的重新制定的补充申请。 这样的 NIDDKD已提交申请并批准资助 理事会于1988年初成立，但为该机构设定了资金“上限” 糖尿病中心导致行政撤回该提案。 一 随后，“核心”的缩小版得到了装备和启动 与机构资金，促进进入几个中心 分子领域的研究者。 戏剧性地注入分子 在过去的五年里， 多年来，加上最近招募的杰克狄克逊，博士，一个杰出的 糖尿病相关的分子生物学家在指导一个 糖尿病中心分子生物学核心，充分证明启动 一个全面的分子生物学核心，以提高糖尿病和内分泌- 通过提供具有成本效益的服务， 加强调查人员研究活动的方法， 引进和利用现代分子技术， 合作并提供最先进的方法和培训， 研究人员在分子生物学领域，通过提供 分子结构和功能分析的基础 产生研究基因调控所必需的工具， 提供疾病标志物，以进一步了解和治疗 糖尿病及其并发症和相关的内分泌和代谢 紊乱

In anticipation of the revolutionary impact that the techniques of molecular biology would have on diabetes research, the Michigan Diabetes Research and Training Center (MDRTC) proposed a Molecular Biology Core (MBC) to introduce these techniques to its investigators as part of its 1986 Competing Renewal Application. Because the relevant research base was just being established, a joint core with the Center for Reproductive and Developmental Biology was proposed. Weakness of the research base, and administrative concerns about joint supervision led to disapproval of the core, with a strong admonition for a subsequent reformulated supplemental application. Such an application was submitted and approved for funding by the NIDDKD Council in early 1988, but the institution of a funding "cap" for the Diabetes Center led to administrative withdrawal of the proposal. A scaled-down version of the Core was subsequently equipped and initiated with institutional funds, facilitating the entry of several Center investigators into the molecular realm. Dramatic infusion of molecular techniques into the Diabetes Center research base over the last five years, plus the recent recruitment of Jack Dixon, PhD, an outstanding diabetes-related molecular biologist experienced in directing a Diabetes Center Molecular Biology Core, full justify the initiation of a full-scale Molecular Biology Core to enhance diabetes and endocrine- related molecular research at the Center by providing cost-effective methods for enhancing research activities among investigators, by introducing and exploiting modern molecular techniques, by fostering collaboration and providing state-of-the-art methods and training to investigators in the area of molecular biology, by providing the foundation for analysis of molecular structures and function as well as generating the tools necessary to study gene regulation, and by providing disease markers to further the understanding and treatment of diabetes, its complications and related endocrine and metabolic disorders.